A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

Status unconfirmed · Phase 4

Conditions studied: Gestational Hypertension, Toxemia, Superimposed Preeclampsia, Eclampsia, HELLP Syndrome

In brief

The investigators aim to determine if Vitamin D prophylaxis in pregnancy reduces the incidence of hypertensive disorders of pregnancy.

Key facts

Study ID

NCT02920593

Run by

Stony Brook University

People needed

412

Starts

2016-10-01

Expected to finish

2019-03-31

Last updated by the study team

2017-10-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age and older
• With a confirmed intrauterine pregnancy, less than 16 weeks gestation
• Carrying a singleton gestation

You may not qualify if…

• Taking Vitamin D supplementation outside of prenatal vitamins
• Has a known disorder that will affect vitamin D levels (i.e, hyperparathyroidism, mal-absorption disorder, history of gastric bypass surgery, immunocompromised state, maternal use of immune-modulators etc.)
• Carrying a fetus with known aneuploidy or anomaly
• With fetal demise
• Women with chronic diuretic or cardiac medication therapy including calcium channel blockers

Where it is running

• SUNY Stony Brook Hospital — Stony Brook, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.